No Data
No Data
Express News | Intellia Therapeutics Inc : Leerink Partners Cuts Target Price to $60 From $68
Intellia Therapeutics Announces New Date for Upcoming Investor Webcast
Intellia Therapeutics Inc (NTLA) Q2 2024 Earnings Call Highlights: Strategic Advances and ...
Cathie Wood's ARK Sheds Robinhood Stock, Adds to Amazon and Coinbase
Truist Financial Maintains Intellia Therapeutics(NTLA.US) With Buy Rating
Truist Financial Initiates a Buy Rating on Intellia Therapeutics (NTLA)
No Data
No Data